Animal model of autoimmune-induced atherosclerosis : Clinical significance of autoantibody against apolipoprotein A-I
Animal model of autoimmune-induced atherosclerosis : Clinical significance of autoantibody against apolipoprotein A-I
批准号:
08557133
负责人:
UMEDA Masato
金额:
$5.25万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Apolipoprotein A-I (apoA-I) is the major protein contituent of HDL, in which apoA-I plays an important role in extracellular lipid transport and metabolism. ApoA-I is an activator of lichithin-cholesterol acyltransferase, and several studies have indicated that apoA-I plays a role as a ligand capable of interacting with the cellular binding site for HDL.This study provides the first information about natural autoantibodies against apoA-I in normal individuals. We showed that the anti-apoA-I autoantibodies bound effectively to oxidized HDL and also to apoA-I complexed with oxidized lipids. The epitope for the anti-apoA-I autoantibody was localized to N-terminus end of apoA-I, suggesting that the lipid peroxidation of HDL may cause a conformational change of apoA-I, resulting in the exposure of the N-terminal autologous antigenic site for the autoantibodies against apoA-I.We also found that serum level of anti-apoA-I autoantibody was reversely correlated with the serum concentration of HDL, implying the autoantibody plays a role in clearance of oxidixed HDL.Immunoglobulin gene sequences of the autoantibodies were also determined.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Suzuki et al.: "Factor VIII Ise (R2159C) is a patient with mild hemophilia A,an abnormal factor VIII with retention of function but modification of C2 epitopes." Thromb.Haemostas.77. 862-867 (1997)
H.Suzuki 等人:“因子 VIII Ise (R2159C) 是一名患有轻度血友病 A 的患者,这是一种异常因子 VIII,保留了功能,但 C2 表位发生了修饰。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
蘭風花ら: "Extended fitmess of variable region primers by a novel PCR protocol" J.Immunol.Methods. 195. 27-32 (1996)
Ranfuka 等人:“通过新型 PCR 方案扩展可变区引物的适应性”J.Immunol.Methods 195. 27-32 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Umeda: "Characterization of autoantibody against apolipoprotein A-I" Rinsho-Seijinbyo. 27. 1356-1358 (1997)
M.Umeda:“针对载脂蛋白 A-I 的自身抗体的表征”Rinsho-Seijinbyo。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
今井正ら: "ホスファチジルセリンは活性化第VIII因子の失活を促進させる" 血栓止血誌. 9. 426-438 (1998)
Tadashi Imai 等人:“磷脂酰丝氨酸促进活化因子 VIII 的失活”《血栓形成与止血杂志》9. 426-438 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
F.Lan et al.: "Extended fitmess of variable region primers by a novel PCR protocol." J.Immunol.Methods. 195. 27-32 (1996)
F.Lan 等人:“通过新颖的 PCR 方案扩展了可变区引物的适应性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
.
-
批准号:17H03805
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2017
-
负责人:UMEDA Masato
-
依托单位:
Molecular mechanisms of commensal bacteria-mediated thermoregulation
-
批准号:25670119
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:UMEDA Masato
-
依托单位:
Molecular mechanisms linking energy metabolism and thermoregulation
-
批准号:22390014
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2010
-
负责人:UMEDA Masato
-
依托单位:
Systemic search for genes that confer tolerance to chronic cold exposure in Drosophila
-
批准号:22659048
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.92万
-
财政年份:2010
-
负责人:UMEDA Masato
-
依托单位:
Molecular mechanisms of functional differentiation and morphogenesis of cell membranes based on the positional information of membrane phospholipids
-
批准号:15207015
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.28万
-
财政年份:2003
-
负责人:UMEDA Masato
-
依托单位:
Identification of phospholipid translocase and its role in cell polarity formation.
-
批准号:12480220
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2000
-
负责人:UMEDA Masato
-
依托单位:
Membrane phospholipid dynamics and cytoskeletal organization: Regulation of actin filament assembly by redistribution of membrane surface phospholipid
-
批准号:09480201
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.08万
-
财政年份:1997
-
负责人:UMEDA Masato
-
依托单位:
Phospholipid translocase : Its role in cytoskeletal reorganization.
-
批准号:07680788
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:UMEDA Masato
-
依托单位:
Role of phosphatidylserine in the activation of blood coagulation factor VIII.
-
批准号:04671343
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:UMEDA Masato
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: